郑州大学学报(医学版)
鄭州大學學報(醫學版)
정주대학학보(의학판)
JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES)
2014年
3期
349-351
,共3页
王海楠%祁元明%高艳锋%周哲骏%李志勤%杜军波%李建斌%张毅
王海楠%祁元明%高豔鋒%週哲駿%李誌勤%杜軍波%李建斌%張毅
왕해남%기원명%고염봉%주철준%리지근%두군파%리건빈%장의
HLA-A2%肿瘤%免疫治疗%慢性丙型肝炎%白癜风
HLA-A2%腫瘤%免疫治療%慢性丙型肝炎%白癜風
HLA-A2%종류%면역치료%만성병형간염%백전풍
HLA-A2%tumor%immunotherapy%chronic hepatitis C%vitiligo
目的:分析河南地区肿瘤、慢性丙型肝炎、白癜风患者HLA-A2的分布频率。方法:应用流式细胞术和聚合酶链反应/序列特异性引物( PCR-SSP)技术检测分析了72例健康人(正常对照)和438例肿瘤患者、110例慢性丙型肝炎患者、97例白癜风患者外周血中HLA-A2抗原的分布频率。结果:肿瘤、慢性丙型肝炎、白癜风患者中HLA-A2抗原的分布频率分别为49.1%、39.0%、47.4%,与正常对照组的48.6%比较,差异均无统计学意义(χ2=0.006,1.611,0.230,P均>0.05)。病例数超过50的肺癌(91例)、胃癌(56例)和食管癌(126例)患者中HLA-A2分布频率分别为42.9%、57.1%和38.0%,与正常对照比较,差异亦无统计学意义(χ2=0.537,0.919,2.081,P均>0.05)。结论:河南肿瘤、慢性丙型肝炎及白癜风患者HLA-A2的分布无特异性,因此HLA-A2限制性的生物细胞免疫治疗具有广泛的应用价值。
目的:分析河南地區腫瘤、慢性丙型肝炎、白癜風患者HLA-A2的分佈頻率。方法:應用流式細胞術和聚閤酶鏈反應/序列特異性引物( PCR-SSP)技術檢測分析瞭72例健康人(正常對照)和438例腫瘤患者、110例慢性丙型肝炎患者、97例白癜風患者外週血中HLA-A2抗原的分佈頻率。結果:腫瘤、慢性丙型肝炎、白癜風患者中HLA-A2抗原的分佈頻率分彆為49.1%、39.0%、47.4%,與正常對照組的48.6%比較,差異均無統計學意義(χ2=0.006,1.611,0.230,P均>0.05)。病例數超過50的肺癌(91例)、胃癌(56例)和食管癌(126例)患者中HLA-A2分佈頻率分彆為42.9%、57.1%和38.0%,與正常對照比較,差異亦無統計學意義(χ2=0.537,0.919,2.081,P均>0.05)。結論:河南腫瘤、慢性丙型肝炎及白癜風患者HLA-A2的分佈無特異性,因此HLA-A2限製性的生物細胞免疫治療具有廣汎的應用價值。
목적:분석하남지구종류、만성병형간염、백전풍환자HLA-A2적분포빈솔。방법:응용류식세포술화취합매련반응/서렬특이성인물( PCR-SSP)기술검측분석료72례건강인(정상대조)화438례종류환자、110례만성병형간염환자、97례백전풍환자외주혈중HLA-A2항원적분포빈솔。결과:종류、만성병형간염、백전풍환자중HLA-A2항원적분포빈솔분별위49.1%、39.0%、47.4%,여정상대조조적48.6%비교,차이균무통계학의의(χ2=0.006,1.611,0.230,P균>0.05)。병례수초과50적폐암(91례)、위암(56례)화식관암(126례)환자중HLA-A2분포빈솔분별위42.9%、57.1%화38.0%,여정상대조비교,차이역무통계학의의(χ2=0.537,0.919,2.081,P균>0.05)。결론:하남종류、만성병형간염급백전풍환자HLA-A2적분포무특이성,인차HLA-A2한제성적생물세포면역치료구유엄범적응용개치。
Aim:To investigate HLA-A2 frequencies in the patients either with cancer or chronic hepatitis C , or vitili-go in Henan Province .Methods:The frequencies of HLA-A2 in 72 healthy people , 438 patients with tumors , 110 patients with chronic hepatitis C , and 97 patients with vitiligo , were detected by flow cytometry and PCR sequence specific primer (PCR-SSP).Results:The frequencies of HLA-A2 in patients with tumors, chronic hepatitis C, and vitiligo were 49.1%, 39.0%, and 47.4%,respectively,which had no significant differences from that of 48.6% in the healthy people (χ2 =0.006,1.611,0.230,P>0.05).The frequencies of HLA-A2 in patients with lung cancer(91 cases), gastric cancer(56 cases),and esophageal cancer (126 cases) were 42.9%,57.1%and 38.0%,which had no significant differences from that of the healthy people(χ2 =0.537,0.919,2.081,P>0.05).Conclusion:HLA-A2 is widely expressed in Henan popula-tion and it is valuable of applying HLA-A2 restricted immunotherapy for Henan population .